{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:47:28Z","timestamp":1762004848880,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:00:00Z","timestamp":1481068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ymgmr.2016.12.003","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T19:15:53Z","timestamp":1481656553000},"page":"20-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Low dose clozapine controls adult-onset psychosis associated with the neurogenic ataxia-retinitis pigmentosa (NARP) mutation"],"prefix":"10.1016","volume":"10","author":[{"given":"Caroline","family":"Demily","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlyne","family":"Duwime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Poisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Boddaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Munnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2016.12.003_bb0005","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ejhg.2011.124","article-title":"Maternally inherited mitochondrial DNA disease in consanguineous families","volume":"19","author":"Alston","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ymgmr.2016.12.003_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","article-title":"Seizure associated with clozapine: incidence, etiology and management","volume":"29","author":"Williams","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ymgmr.2016.12.003_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ymgmr.2016.12.003_bb0020","first-page":"1163","article-title":"Clinical pharmacology of antipsychotics: an update","volume":"13","author":"Mauri","year":"2014","journal-title":"EXCLI J"},{"key":"10.1016\/j.ymgmr.2016.12.003_bb0025","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1471-4159.2006.03990.x","article-title":"The role of mitochondria in inherited neurodegenerative diseases","volume":"97","author":"Kwong","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.ymgmr.2016.12.003_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11920-016-0730-1","article-title":"Current understanding of psychosis in Parkinson's disease","volume":"18","author":"Ojo","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.ymgmr.2016.12.003_bb0035","article-title":"The efficacy and safety of antipsychotic medications in the treatment of psychosis in patients with Parkinson's disease","volume":"4938154","author":"Divac","year":"2016","journal-title":"Behav Neurol"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426916301355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426916301355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:49:31Z","timestamp":1762001371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426916301355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":7,"alternative-id":["S2214426916301355"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2016.12.003","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low dose clozapine controls adult-onset psychosis associated with the neurogenic ataxia-retinitis pigmentosa (NARP) mutation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}